Health Score

0 Good

Metadata coverage

Abstract

ORCID

References

License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder

Award / grant

Affiliation & institutional identifiers

Affiliation

ROR ID

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

Add abstracts to 228 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact228 DOIs

Attach ORCID iDs across 68 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact68 DOIs

Deposit reference lists for 7 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact7 DOIs

DOIs for this ISSN

Showing the top 5 of 228 DOIs, ordered by correction priority.

#	Title	Missing	Priority	Citations
1	VTE epidemiology and challenges for VTE prevention at the po… (10.1016/j.tru.2023.100132)	Abstract ORCID	81.16	41
2	Advancing anticoagulation stewardship: A call to action for… (10.1016/j.tru.2022.100125)	Abstract ORCID	61.52	16
3	Thrombotic complications after hematopoietic stem cell trans… (10.1016/j.tru.2024.100186)	Abstract ORCID	61.52	16
4	Thrombosis of pulmonary vasculature despite anticoagulation… (10.1016/j.tru.2020.100017)	Abstract ORCID	60.21	15
5	Antiplatelet therapy in patients with Covid-19: A retrospect… (10.1016/j.tru.2020.100026)	Abstract ORCID	55.70	12
6	The role of the PERT team in 2021 (10.1016/j.tru.2021.100092)	Abstract ORCID	55.70	12
7	Thrombosis: Current knowledge based on metabolomics by nucle… (10.1016/j.tru.2020.100011)	Abstract ORCID	53.96	11
8	Direct oral anticoagulant blood level monitoring in daily pr… (10.1016/j.tru.2021.100049)	Abstract ORCID	53.96	11
9	The role of the fibrinolytic system in female reproductive d… (10.1016/j.tru.2020.100004)	Abstract ORCID	47.71	8
10	Intervention in COVID-19 linked hypercoaguable states charac… (10.1016/j.tru.2020.100009)	Abstract ORCID	42.25	6
11	Incidence, risk factors and clinical outcome of venous throm… (10.1016/j.tru.2021.100056)	Abstract ORCID	42.25	6
12	Inherited antithrombin deficiency in pregnancy (10.1016/j.tru.2021.100094)	Abstract ORCID	42.25	6
13	Negatively charged phospholipids stimulate factor XI activat… (10.1016/j.tru.2020.100022)	Abstract ORCID	38.91	5
14	Vaccine-induced thrombosis and thrombocytopenia (VITT) in Ir… (10.1016/j.tru.2021.100086)	Abstract ORCID	38.91	5
15	The current landscape of factor XI inhibitors (10.1016/j.tru.2024.100171)	Abstract ORCID	38.91	5
16	Thrombosis in myeloproliferative neoplasms: A clinical and p… (10.1016/j.tru.2021.100081)	Abstract	38.60	34
17	Surviving and thriving in thrombosis research during a globa… (10.1016/j.tru.2020.100028)	Abstract ORCID	34.95	4
18	Edoxaban dosing patterns in real life practice – Results fro… (10.1016/j.tru.2021.100070)	Abstract ORCID	34.95	4
19	Risk assessment models of cancer-associated thrombosis - Pot… (10.1016/j.tru.2021.100075)	Abstract	34.95	24
20	The interplay between inflammation and thrombosis in COVID-1… (10.1016/j.tru.2022.100117)	Abstract	34.95	24
21	A rare case of thrombotic thrombocytopenic purpura during pr… (10.1016/j.tru.2024.100172)	Abstract ORCID	34.95	4
22	Accuracy of venous thromboembolism ICD-10 codes: A systemati… (10.1016/j.tru.2023.100154)	Abstract	34.04	22
23	Role of tissue-factor bearing extracellular vesicles release… (10.1016/j.tru.2020.100020)	Abstract	31.38	17
24	The mechanistic basis linking cytokine storm to thrombosis i… (10.1016/j.tru.2022.100110)	Abstract	31.38	17
25	Enhanced thromboprophylaxis in critically ill patients with… (10.1016/j.tru.2021.100048)	Abstract ORCID	30.10	3
26	Updates on thrombotic thrombocytopenic purpura: Recent devel… (10.1016/j.tru.2021.100062)	Abstract	30.10	15
27	Screening for venous thrombotic events in patients presentin… (10.1016/j.tru.2021.100091)	Abstract ORCID	30.10	3
28	Tumour-associated Mucin1 correlates with the procoagulant pr… (10.1016/j.tru.2022.100123)	Abstract ORCID	30.10	3
29	Real-world treatment of patients with severe congenital prot… (10.1016/j.tru.2024.100159)	Abstract ORCID	30.10	3
30	Tissue factor (F3) gene variants and thrombotic risk among m… (10.1016/j.tru.2024.100190)	Abstract ORCID	30.10	3
31	Value of hospital anticoagulation stewardship programme: A s… (10.1016/j.tru.2023.100158)	Abstract	29.40	14
32	Acute limb ischemia in a COVID-19 patient (10.1016/j.tru.2020.100031)	Abstract	28.65	13
33	Risk factors for Venous Thromboembolism and clinical outcome… (10.1016/j.tru.2022.100101)	Abstract	28.65	13
34	The thrombotic spectrum of B-thalassemia (10.1016/j.tru.2022.100102)	Abstract	28.65	13
35	Clinical characteristics and outcomes of venous thromboembol… (10.1016/j.tru.2021.100037)	Abstract	27.85	12
36	COVID-19, thrombosis and pregnancy (10.1016/j.tru.2021.100077)	Abstract	26.98	11
37	Fibrinolysis shut down in COVID-19 patients: Report on two s… (10.1016/j.tru.2020.100008)	Abstract	26.03	10
38	No changes of parameters nor coagulation activation in healt… (10.1016/j.tru.2021.100059)	Abstract	26.03	10
39	Risk assessment for recurrent venous thromboembolism in pati… (10.1016/j.tru.2021.100080)	Abstract	26.03	10
40	Systematic testing for venous thromboembolism in hospitalize… (10.1016/j.tru.2020.100029)	Abstract	25.00	9
41	Update on pregnancy-associated venous thromboembolism (10.1016/j.tru.2022.100107)	Abstract	25.00	9
42	Development of a brief screening instrument for emotional di… (10.1016/j.tru.2020.100015)	Abstract ORCID	23.86	2
43	Mortality, critical illness, and mechanical ventilation amon… (10.1016/j.tru.2020.100027)	Abstract	23.86	8
44	Disseminated intravascular coagulation in pregnancy: New ins… (10.1016/j.tru.2021.100083)	Abstract	23.86	8
45	Venous thromboembolism risk, prophylaxis and management in c… (10.1016/j.tru.2022.100098)	Abstract ORCID	23.86	2
46	Implementation of a care pathway for deep vein thrombosis: W… (10.1016/j.tru.2022.100109)	Abstract ORCID	23.86	2
47	Bleeding and venous thromboembolism events in cancer patient… (10.1016/j.tru.2022.100129)	Abstract ORCID	23.86	2
48	Clinical characteristics of patients with direct oral antico… (10.1016/j.tru.2023.100139)	Abstract ORCID	23.86	2
49	Evaluation of the diagnostic performance of three D-dimer as… (10.1016/j.tru.2023.100147)	Abstract ORCID	23.86	2
50	Update on extended prophylaxis for venous thromboembolism fo… (10.1016/j.tru.2021.100038)	Abstract	22.58	7